Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Healed Patient Rochelle Sliwinski Credits International Topical Steroid Awareness Network for the Cure to Her Steroid Induced Eczema
  • USA - English


News provided by

ITSAN: International Topical Steroid Awareness Network

Feb 18, 2014, 15:25 ET

Share this article

Share toX

Share this article

Share toX

Rochelle's Healing Story Pics
Rochelle's Healing Story Pics

(PRWEB) February 18, 2014 -- Rochelle is very thankful for the International Steroid Awareness Network (ITSAN ) as she is one of many who joined their mission due to worsening eczema. She used topical steroids for about five years on and off for eczema that first appeared at age six. The brief use of the cream cleared it up but the eczema returned on her lips at age 16 so she used topical steroids again briefly and then again at age twenty due to a reaction from makeup applied on her eyelids.

I just want to say I'm completely amazed by how many views this blog continues to get, and moreso, how fast ITSAN is growing, and how many people from all over the world are learning about Topical Steroid Addiction thanks to the amazing non-profit.

Post this

Rochelle chased that outbreak with steroids until the rash developed on her lips which caused her to use steroids habitually at that point. She noticed the rashes only intensified after using more and more potent strengths of the medication. Eventually the cream stopped working and she was left with a rash that spread uncontrollably.

Feeling hopeless about her situation, she went to the internet to search for answers. To her surprise she found a patient led advocacy group for skin sufferers called ITSAN. The group at that time, comprised of over 600 individuals grappling with withdrawals from topical steroids after realizing they had developed a dependence to the strong drug used for various types of skin conditions.

Steroid induced eczema is also called "red skin syndrome" which is an iatrogenic illness caused by the medical treatment used to treat it. It typically starts with a prescription of topical steroids for eczema or other types of skin inflammation. Over time the condition becomes difficult to manage with the same prescription. The patient becomes addicted to the medication, exhibiting worsening symptoms when stopping it. Fortunately, the problem ends with complete cessation of topical steroids, although it is followed by a slow and painful withdrawal process that usually takes a year or longer to heal.

Rochelle was shocked when she learned her medicine was causing the problem.

"When I received the topical steroid from the doctor, I thought it was a harmless cream or moisturizer similar to what you buy over-the-counter, but stronger. After finding ITSAN, I read the fine print on my prescription closer. The label said, corticosteroids can suppress the HPA axis. My physician at the time failed to let me know exactly what that meant. Those symptoms are exactly what I and many others in the support group are suffering from right now. Symptoms like worsening and spreading eczema to body areas where we never applied the steroid before, hot, red skin, oozing, burning. The worst symptom of all was the itching. Incessant, crazy itching! Itching so bad you want to pull your hair out and scream atop the cliffs of the Grand Canyon! Itching that prevents you from sleeping at night, itching that makes you cry out for help!" Exclaimed, Rochelle. "I am so thankful to finally receive a correct diagnosis when I visited Dr. Rapaport."

Dr. Rapaport is a dermatologist who discovered and named it "Red Skin Syndrome" while working at UCLA'S dermatology clinic. Prior to this, a dermatologist by the name of Albert M. Kligman discovered steroid addiction in the late 1970s. Dr. Fukaya of Japan is also a pioneer doctor with regard to this condition and saw many patients in his clinic as well.

"Rochelle serves as a shining example for other ITSAN members to follow. While using topical steroids she unknowingly got addicted. She was once at a loss for answers on her condition like so many others in the ITSAN support forum. She found help and with determination and support, she endured the hellish withdrawal. After 19 months of patiently struggling with incessant painful and itchy symptoms, her body finally recovered and is fully healed. Now she helps guide new sufferers toward feelings of greater hope and optimism," said Kelly Palace, President & Co-Founder of ITSAN.

Rochelle started a blog called "Curing Red Skin Syndrome" to chronicle her recovery and to spread more awareness about this debilitating condition. Her blog has over 40,000 visits since starting it in 2011 and she also made this video of her journey.

ITSAN, ITSAN: International Topical Steroid Awareness Network, http://www.itsan.org, +1 1-321-704-9304, [email protected]

Modal title

Learn More on Steroid Addiction
View PDF
Learn More on Steroid Addiction
Learn More on Steroid Addiction

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.